Clinical Trial Update: Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate [Phase 1]

View source ↗

Summary

Phase 1 trial investigating gene-expression changes during chemotherapy in newly diagnosed acute myeloid leukemia patients treated with Choline Magnesium Trisal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Choline Magnesium Trisalicylate (Choline magnesium trisalicylate)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Leukemia | Phase 1 | Status: TERMINATED